首页>Arteriosclerosis, thrombosis, and vascular biology>Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+monocyte counts that predict cardiovascular events in chronic kidney disease
Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+monocyte counts that predict cardiovascular events in chronic kidney disease
作者单位:Department of Internal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center[1]Department of Medicine, Imperial College London, London, United Kingdom[2]Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland[3]